Interestingly, Metzner et al. believed that PTGS2 inhibitor had a dual effect on atherosclerosis: promoting the occurrence and development of atherosclerosis in the early stage of atherosclerosis, but playing a protective role against atherosclerosis in the late stage of atherosclerosis (40). The gene discussed is PTGS2; the disease is atherosclerosis.